PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-3.67
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
2536.67
P/S of 2536.67 while RVPH has no sales. Bruce Berkowitz would examine revenue quality advantage.
1.46
P/B 1.1-1.25x RVPH's 1.26. Bill Ackman would demand evidence of superior asset utilization.
4.13
Positive FCF while RVPH shows negative FCF. John Neff would investigate cash generation advantage.
4.09
Positive operating cash flow while RVPH shows negative OCF. John Neff would investigate operational advantage.
1.46
Fair value ratio 1.1-1.25x RVPH's 1.26. Bill Ackman would demand evidence of superior economics.
-6.80%
Both companies show losses. Martin Whitman would check for industry-wide issues.
24.22%
Positive FCF while RVPH shows negative FCF. John Neff would investigate cash generation advantage.